Charlotte Hedin

5.4k total citations · 1 hit paper
58 papers, 1.8k citations indexed

About

Charlotte Hedin is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Charlotte Hedin has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Genetics, 18 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Charlotte Hedin's work include Inflammatory Bowel Disease (40 papers), Microscopic Colitis (17 papers) and Gut microbiota and health (13 papers). Charlotte Hedin is often cited by papers focused on Inflammatory Bowel Disease (40 papers), Microscopic Colitis (17 papers) and Gut microbiota and health (13 papers). Charlotte Hedin collaborates with scholars based in Sweden, United Kingdom and United States. Charlotte Hedin's co-authors include James O. Lindsay, Kevin Whelan, Andrew J. Stagg, Neil E. McCarthy, Eduardo J. Villablanca, Siew C. Ng, Jane Benjamin, Alastair Forbes, Jeremy Sanderson and Nicholas M. Croft and has published in prestigious journals such as Journal of Clinical Investigation, Immunity and Nature Biotechnology.

In The Last Decade

Charlotte Hedin

47 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?

2022 141 citations Eduardo J. Villablanca, Charlotte Hedin et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Countries citing papers authored by Charlotte Hedin

Since Specialization

Citations

This map shows the geographic impact of Charlotte Hedin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Hedin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Hedin more than expected).

Fields of papers citing papers by Charlotte Hedin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Hedin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Hedin. The network helps show where Charlotte Hedin may publish in the future.

Co-authorship network of co-authors of Charlotte Hedin

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Hedin. A scholar is included among the top collaborators of Charlotte Hedin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Hedin. Charlotte Hedin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study 2025 ·BJS Open ·Erik Stenberg, Åsa H. Everhov, Jonas Söderling, Johan Ottosson, Mehdi Osooli, (unknown), Pär Myrelid, Hans Strid, Caroline Nordenvall, Charlotte Hedin, Susanna Jäghult, (unknown), O Grip, Ulrika L. Fagerberg, Karl Mårild, Ellen Andersson, Daniel Bergemalm, Jonas F. Ludvigsson, Carl Eriksson, Ola Olén	0
2	Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study 2025 ·Journal of Crohn s and Colitis ·Jordan E. Axelrad, Anders Forss, (unknown), Karl Mårild, Jonas Halfvarson, Pontus Nauclér, Jonas F. Ludvigsson, Ola Olén, (unknown), Pär Myrelid, (unknown), Hans Strid, Marie Andersson, Susanna Jäghult, Caroline Nordenvall, Charlotte Hedin, (unknown), Olof Grip, Ulrika L. Fagerberg, Jóhann P. Hreinsson	0
3	Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Christer Peterson, Charlotte Hedin, Daniel Bergemalm, Maria Lampinen, Maria K. Magnusson, Åsa V. Keita, (unknown), C. Lindqvist, Dirk Repsilber, Mauro D’Amato, (unknown), Hans Strid, Johan D. Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson	7
4	Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study 2024 ·Journal of Crohn s and Colitis ·(unknown), Padhmanand Sudhakar, Daniel Bergemalm, (unknown), (unknown), Marie Carlson, Charlotte Hedin, Johan D. Söderholm, Lena Öhman, C. Lindqvist, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
5	P1113 Depressive symptoms in ulcerative colitis and Crohn's disease – differences in improvement at 1 year follow-up 2024 ·Journal of Crohn s and Colitis ·(unknown), Dirk Repsilber, (unknown), C. Lindqvist, Robert L. Kruse, Maria K. Magnusson, Lena Öhman, Marie Carlson, Åsa V. Keita, Johan D. Söderholm, Jonas Halfvarson, Charlotte Hedin	0
6	Human skin-resident CD8+ T cells require RUNX2 and RUNX3 for induction of cytotoxicity and expression of the integrin CD49a 2023 ·Immunity ·Béatrice Zitti, Elena Hoffer, (unknown), (unknown), Heinrich Schlums, (unknown), (unknown), Lien Nguyen, Jaanika Kärner, Efthymia Kokkinou, Anna Carrasco, Jessica Gahm, Marcus Ehrström, (unknown), Åsa V. Keita, Charlotte Hedin, Jenny Mjösberg, Liv Eidsmo, Yenan T. Bryceson	30
7	Inflammatory Bowel Disease Is not Linked to a Higher Rate of Adverse Events in Colonoscopy—a Nationwide Population-based Study in Sweden 2023 ·Journal of Crohn s and Colitis ·(unknown), Anna Andréasson, Charlotte Hedin, Gabriella Bröms, Peter T. Schmidt, Anna Forsberg	0
8	Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression? breakdown → 2022 ·Nature Reviews Gastroenterology & Hepatology ·Eduardo J. Villablanca, (unknown), Charlotte Hedin	141
9	Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register 2022 ·United European Gastroenterology Journal ·(unknown), (unknown), Charlotte Hedin, Anders Forss, Charlotte Söderman, Daniel Bergemalm, (unknown), Ola Olén, Henrik Hjortswang, Hans Strid, Jonas F. Ludvigsson, Carl Eriksson, Jonas Halfvarson	29
10	Scalable in situ single-cell profiling by electrophoretic capture of mRNA using EEL FISH 2022 ·Nature Biotechnology ·Lars E. Borm, Alejandro Mossi Albiach, (unknown), (unknown), (unknown), (unknown), Rebecca D. Hodge, Francisca Castillo, Charlotte Hedin, Eduardo J. Villablanca, Per Uhlén, Ed S. Lein, Simone Codeluppi, Sten Linnarsson	65
11	Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease 2021 ·Journal of Crohn s and Colitis ·Joana Torres, Jonas Halfvarson, Iago Rodríguez–Lago, Charlotte Hedin, Tine Jess, Marla Dubinsky, Kenneth Croitoru, Jean‐Frédéric Colombel	42
12	523 T-cell cytokines (IL-17 and IFN-γ) exacerbates innate immune responses in an organotypic human psoriasis tissue model 2019 ·Journal of Investigative Dermatology ·Seyoum Ayehunie, T. Landry, Charlotte Hedin, (unknown), Patrick Hayden, Mitchell Klausner	1
13	Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings 2014 ·Gut ·Charlotte Hedin, Neil E. McCarthy, Petra Louis, Freda M. Farquharson, Sara McCartney, Kirstin M. Taylor, Natalie J. Prescott, Trevor Murrells, Andrew J. Stagg, Kevin Whelan, James O. Lindsay	125
14	OC-009 Human anti-microbial vδ2+ t-cells are novel intestinal lymphocytes with functional relevance in crohn's disease 2012 ·Gut ·Neil E. McCarthy, Charlotte Hedin, Anna Vossenkämper, (unknown), (unknown), Theodore J. Sanders, Edward Giles, Kevin Whelan, James O. Lindsay, Andrew J. Stagg	1
15	Brand consistency : A case study of Stadium 2011 ·Borås Academic Digital Archive (University of Borås) ·Charlotte Hedin, (unknown)	0
16	Adolescents with IBD: The importance of structured transition care 2011 ·Journal of Crohn s and Colitis ·James Goodhand, Charlotte Hedin, Nicholas M. Croft, James O. Lindsay	91
17	Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease 2011 ·Gut ·Jane Benjamin, Charlotte Hedin, (unknown), Siew C. Ng, Neil E. McCarthy, AL Hart, M A Kamm, Jeremy Sanderson, S C Knight, Alastair Forbes, Andrew J. Stagg, Kevin Whelan, JO Lindsay	252
18	Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention: Figure 1 2011 ·Gut ·Charlotte Hedin, Andrew J. Stagg, Kevin Whelan, James O. Lindsay	34
19	Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohnʼs disease 2010 ·Inflammatory Bowel Diseases ·Siew C. Ng, Jane Benjamin, Neil E. McCarthy, Charlotte Hedin, Andreas Koutsoumpas, Sophie Plamondon, Claire Price, Ailsa Hart, Michael A. Kamm, Alastair Forbes, Stella C. Knight, James O. Lindsay, Kevin Whelan, Andrew J. Stagg	93
20	Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials 2007 ·Proceedings of The Nutrition Society ·Charlotte Hedin, Kevin Whelan, James O. Lindsay	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact